Predicting Oxycodone Dose From Oral Fluid Drug Levels
CompletedNCT01928303
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study will develop and test an algorithm that will estimate drug dosage from drug levels measured in oral fluid (saliva). Traditionally, urine has been used as the principle medium to monitor drug compliance in patients receiving opioids for chronic pain as well as those being treated for substance abuse. Recently, the use of saliva as an alternative to urine drug testing has been gaining in popularity. Oral fluid has several advantages over urine as a medium for drug screening. In this study, oral fluid, urine and blood specimens will be collected from volunteer patient donors with chronic pain taking opioid medications. Samples from the anonymous donor will be analyzed for opiate class drugs, using New York State Department of Health approved and validated laboratory methods. Analytical results and other information collected will assist in evaluating the use of oral fluid as a specimen to detect opiate drug levels. The measurement of drug concentrations in blood and oral fluid simultaneously will allow for the determination of the amount of oral fluid that will be needed for successful drug testing. It is proposed that by measuring oral fluid drug levels an estimate of the amount of drug taken will be possible.
Study details
- Official title
- Predicting Oxycodone Dose From Oral Fluid Drug Levels For Chronic Pain Management Patients
- Conditions
- Sponsor
- Weill Medical College of Cornell University
- Start date
- 2013-03
- Primary completion
- 2014-08
- Sex
- All
- Age range
- from 18 Years to 72 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults between 18 and 72 years of age * Chronic pain patient at Weill Cornell Medical College Pain Medicine Center Exclusion Criteria: * taking any medications that can alter the metabolism of oxycodone or oxymorphone in the body * not a chronic pain patient at Weill Cornell Medical College Pain Medicine Center
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01928303